Omics! Omics!

Many writers have attempted to divide Next Generation Sequencing into Second Generation Sequencing and Third Generation Sequencing.  Persona...

An idea for a little exploration occurred to me back at Infinity -- that is 7.5 years ago -- that I've never tried out.  But I never got...

For as long as I can remember, Covaris has been the standard in DNA shearing for high throughput short read sequencing.  Their benchtop unit...

Here's a dangerous statement for me: I actually enjoyed reading some patents recently.  Now, before you get any ideas in your head about...

Derek Lowe summarized a really cool paper back in October .  I've been meaning to grab a copy, but discovered recently that the MIT libr...

As promised in the last post, I'm segregating out Oxford Nanopore.  Admittedly I tend to cover them relatively closely -- though I never...

An astute reader caught a sentence fragment about MGI in last night's Illumina JPM roundup -- the unfortunate evidence of a a mental ba...

Illumina CEO Francis deSouza delivered his J.P. Morgan Healthcare Conference talk ( webcast audio , slides & Q&A audio ) a week ago...

Next week is the J.P. Morgan Healthcare Conference.  It's striking this year the paucity of companies in the genomics space -- Illumina ...

2019 is upon us; I'm hoping it will be a bit less eventful than 2018.  It wasn't all bad -- I took two trips that delivered scenery ...

I hope my admiration for Pacific Biosciences intellectual acumen was clear in my post on the acquisition by Illumina , because now I'm g...

I'm going to go through some analysis of Oxford Nanopore basecalling, running some quick comparisons using a freely-available tool calle...

Given it's late and I just dashed through a classic San Francisco downpour, I'm going to mostly stick to covering Clive Brown's ...

Nanopore Community Meeting begins within the hour.  San Francisco is spectacular as ever -- Alcatraz Island disappearing into the fog as I f...

Okay, now that I'm done venting -- for now -- about ONT's customer service experience   (well, almost done -- they sent me the same ...

I'd planned today to use some downtime to write up a preview of the Nanopore Community Meeting which I am attending tomorrow and Thursda...

I took one swing at Vijay Pande's overly rosy piece on applying engineering methods to biology and medicine  and similar minded efforts...

Vijay Pande has a thought-provoking piece in Scientific American on the Groves Fallacy , though in the end I'm afraid mostly what he pro...

Illumina surprised pretty much everyone in the genomics community by announcing the purchase of Pacific Biosciences.  I had spent Thursday d...

Yes, it's been way too long since I wrote here.  Even longer since I did so with any regularity.  There was always some list of things d...